NCT00003004View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

DRUG

cisplatin

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003004 - Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter